Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Investor Network Invites You to the DarioHealth Fourth Quarter and Full Year 2016 Earnings Conference Call and Webcast Live on Thursday, March 23, 2017

DRIO

CAESAREA, ISRAEL / ACCESSWIRE / March 22, 2017 / DarioHealth Corp. (NASDAQ: DRIO) will host a conference call and live webcast to discuss the results of fourth quarter and full year 2016, to be held Thursday, March 23, 2017 at 9:00 AM Eastern Time.

Live Event Information

To participate, connect approximately 5 to 10 minutes before the beginning of the event.

- Date, Time: March 23, 2017 at 9:00 AM ET - Toll Free: (866) 682-6100 - International: (862) 255-5401 - Live Webcast: www.investorcalendar.com/IC/CEPage.asp?ID=175764

Replay Information

The replay will be available beginning approximately 2 hours after the completion of the live event, ending at midnight Eastern on April 6, 2017.

- Toll Free: 877-481-4010 - International: 919-882-2331 - Replay ID#: 10287 - Webcast: www.investorcalendar.com

About DarioHealth Corp.

DarioHealth is a leader in digital health self-management solutions. DarioHealth delivers the ability to combine and analyze consumer health data to personalize treatment and advance medical knowledge. Dario's™ smart diabetes management solution is a platform for diabetes management that combines the Dario™ Blood Glucose Monitoring System all-in-one blood glucose meter, native smart phone app, website portal, and a wide variety of treatment tools to support more proactive and better informed decisions by users living with diabetes, their doctors, and healthcare systems. Having recently launched in the largest market in the world for glucose monitoring, U.S. sales are expected to have a significant impact on revenues and gross margins. With marketing clearance in Europe and the U.S., the Dario iOS mobile app recently launched with reimbursement in the United Kingdom, Australia, Israel, Italy, and Canada, and has also launched in New Zealand, Netherlands, Italy, and Belgium. For more information, visit http://mydario.investorroom.com/.

SOURCE: Investor Network



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today